Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative

Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative

Solid lipid nanoparticles (SLNs) comprise a versatile drug delivery system that has been developed for the treatment of a variety of diseases. The present study will investigate the feasibility of entrapping an active doxorubicin prodrug (a squalenoyl-derivative) in SLNs. The doxorubicin derivative-...

Full description

Bibliographic Details
Main Authors:	Barbara Stella, Elena Peira, Chiara Dianzani, Marina Gallarate, Luigi Battaglia, Casimiro Luca Gigliotti, Elena Boggio, Umberto Dianzani, Franco Dosio
Format:	Article
Language:	English
Published:	MDPI AG 2018-02-01
Series:	Nanomaterials
Subjects:	solid lipid nanoparticles doxorubicin anticancer agent nanoassemblies anticancer prodrugs
Online Access:	http://www.mdpi.com/2079-4991/8/2/110

Similar Items

Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor
by: Song Yi Lee, et al.
Published: (2018-01-01)

Design and Synthesis of Doxorubicin Conjugated Gold Nanoparticles as Anticancer Drug Delivery System
by: Xia, Long
Published: (2017)

Facile Fabrication of Reduction-Responsive Supramolecular Nanoassemblies for Co-delivery of Doxorubicin and Sorafenib toward Hepatoma Cells
by: Qingqing Xiong, et al.
Published: (2018-02-01)

Glutathione Transferase (GST)-Activated Prodrugs
by: Andrea Calderan, et al.
Published: (2013-04-01)

Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition Concept
by: Mark R. Hellmich, et al.
Published: (2021-07-01)

Development of doxorubicin-loaded chitosan–heparin nanoparticles with selective anticancer efficacy against gastric cancer cells in vitro through regulation of intrinsic apoptosis pathway
by: Huiyu Yang, et al.
Published: (2021-08-01)

Doxorubicin-Wrapped Zinc Oxide Nanoclusters for the Therapy of Colorectal Adenocarcinoma
by: Sungyun Kim, et al.
Published: (2017-10-01)

Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
by: Cinzia Calcabrini, et al.
Published: (2020-05-01)

Synthesis and optimization of niosomal carriers containing doxorubicin in order to achieve a final formulation with high potential in cancer cells temperature and acidity
by: Hashem Shahi Malmir, et al.
Published: (2019-01-01)

Thermosensitive Injectable Hydrogel for Simultaneous Intraperitoneal Delivery of Doxorubicin and Prevention of Peritoneal Adhesion
by: Chih-Hao Chen, et al.
Published: (2018-05-01)

ZnO nanofluids for the improved cytotoxicity and cellular uptake of doxorubicin
by: Safoura Soleymani, et al.
Published: (2018-01-01)

Spatiotemporal Control of Doxorubicin Delivery from “Stealth-Like” Prodrug Micelles
by: Li Kong, et al.
Published: (2017-09-01)

Potential effects of gamma irradiation on the stability and therapeutic activity of anticancer drug, doxorubicin
by: Fatmah M. Alshammari, et al.
Published: (2017-04-01)

Polymeric Nanocarriers: A Transformation in Doxorubicin Therapies
by: Kamila Butowska, et al.
Published: (2021-04-01)

Simultaneous determination of doxorubicin and its dipeptide prodrug in mice plasma by HPLC with fluorescence detection
by: Jing Han, et al.
Published: (2016-06-01)

Development of tumour selective and endoprotease-activated anticancer therapeutics.
by: Gill, Jason H., et al.
Published: (2010)

Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action
by: Ziwen Dai, et al.
Published: (2020-11-01)

Synthesis and Biological Evaluation of Benzodioxole Derivatives as Potential Anticancer and Antioxidant agents
by: Hawash Mohammed, et al.
Published: (2020-11-01)

Enhanced tumor delivery and antitumor response of doxorubicin loaded albumin nanoparticles formulated based on a Schiff base
by: Li F, et al.
Published: (2016-08-01)

Magnetic Particles with Polymeric Shells Bearing Cholesterol Moieties Sensitize Breast Cancer Cells to Low Doses of Doxorubicin
by: Karolina H. Markiewicz, et al.
Published: (2021-05-01)

Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models
by: Monica Argenziano, et al.
Published: (2020-01-01)

Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising its Anticancer Efficacy in Breast Cancer
by: Kavitha Godugu, et al.
Published: (2020-06-01)

Lipidic Cubic-Phase Nanoparticles (Cubosomes) Loaded with Doxorubicin and Labeled with <sup>177</sup>Lu as a Potential Tool for Combined Chemo and Internal Radiotherapy for Cancers
by: Adrianna Cytryniak, et al.
Published: (2020-11-01)

Doxyl Nitroxide Spin Probes Can Modify Toxicity of Doxorubicin towards Fibroblast Cells
by: Jan Czepas, et al.
Published: (2020-11-01)

Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy
by: Jiang Yu, et al.
Published: (2020-09-01)

Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy
by: Lan Li, et al.
Published: (2017-01-01)

Tumor acidity-induced charge-reversal liposomal doxorubicin with enhanced cancer cell uptake and anticancer activity
by: Jinpeng Yang, et al.
Published: (2021-06-01)

Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib
by: Bjoern Bielec, et al.
Published: (2020-03-01)

Preparation, Physicochemical Properties, and In Vitro Toxicity towards Cancer Cells of Novel Types of Arsonoliposomes
by: Paraskevi Zagana, et al.
Published: (2020-04-01)

Synthesis, chemo-informatics, and anticancer evaluation of fluorophenyl-isoxazole derivatives
by: Hawash Mohammed, et al.
Published: (2021-08-01)

Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer
by: Ali H. El-Far, et al.
Published: (2021-08-01)

A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin
by: Zuojun Li, et al.
Published: (2018-08-01)

Wild edible onions — Allium flavum and Allium carinatum — successfully prevent adverse effects of chemotherapeutic drug doxorubicin
by: Pavić Aleksandar, et al.
Published: (2019-01-01)

MIL-100(Al) Gels as an Excellent Platform Loaded with Doxorubicin Hydrochloride for pH-Triggered Drug Release and Anticancer Effect
by: Yuge Feng, et al.
Published: (2018-06-01)

A mathematical model of doxorubicin penetration through multicellular layers,
by: Evans, C.J., et al.
Published: (2010)

Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance
by: Gabriella Spengler, et al.
Published: (2019-01-01)

Doxorubicin-Loaded Delta Inulin Conjugates for Controlled and Targeted Drug Delivery: Development, Characterization, and In Vitro Evaluation
by: Lixin Wang, et al.
Published: (2019-11-01)

The role of bystander effects in the antitumor activity of the hypoxia-activated prodrug PR-104
by: Annika eFoehrenbacher, et al.
Published: (2013-10-01)

Green Synthesis and Biomedical Applications of ZnO Nanoparticles: Role of PEGylated-ZnO Nanoparticles as Doxorubicin Drug Carrier against MDA-MB-231(TNBC) Cells Line
by: Madiha Batool, et al.
Published: (2021-03-01)

Design, Synthesis, and Characterization of Schiff Base Bond-Linked pH-Responsive Doxorubicin Prodrug Based on Functionalized mPEG-PCL for Targeted Cancer Therapy
by: Yinglei Zhai, et al.
Published: (2018-10-01)